Wilczek Mira sold $238K of EVER

Wilczek Mira sold 9,500 shares of EverQuote, Inc. (EVER) at $25.07 ($0.24M total) on 2026-09-01.

Original reporting
SEC EDGAR · Wilczek Mira
Published Sep 3, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 11:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Bearish
medium confidence
Mentioned
$EVER
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment, offering a modest trading cue.

02

Market read

Direct insider sale adds a small negative bias to EverQuote's short-term outlook.

03

What to watch

No 10b5-1 plan; sale may be unrelated to company fundamentals.

Relevance 4/10Novelty 4/10Timing: filed Sep 3, 2026

Background

SEC Form 4 filings disclose insider transactions; director sales are monitored for potential signals.

Company-level read

Ticker impact

$EVERBearishMedium confidence
Context

Director Mira Wilczek sold 9,500 shares of EverQuote for $238,165, reducing her stake to 110,353 shares.

Expected impact

Possible modest downside pressure in the next few trading sessions.

Evidence & confidence

Director sales are closely watched; the amount is modest but could influence sentiment.

Market effects

Minimal impact on insurance/insurtech sector.

Limited to US markets where EverQuote trades.

Low

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • EverQuote, Inc.

    US-listed insurtech firm (ticker EVER).

  • Mira Wilczek

    Director of EverQuote.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.